Metabolomic and inflammatory signatures in congenital hypothyroidism: a longitudinal analysis of levothyroxine response

• by Marcela Vela-Amieva, Isabel Ibarra-González, Raúl Calzada León, María de la Luz Ruiz-Reyes, María Eugenia Constantini, Sara Guillén-López, Lizbeth López-Mejía, Michelle Citlalli Luna-Nequiz, Rosa Itzel Carrillo-Nieto, Cynthia Fernández-Lainez

• July 1, 2026

How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages

“There is incredible uncertainty in drug dosing.”

• by Arthur Allen

• August 20, 2026

• 15 min

10 states that support physician work-life balance

These 10 states have paid family or medical leave programs and health, wellness, peer support, or monitoring resources available to physicians or other health professionals.

• by MDSpire News Staff

• August 27, 2026

• 6 min

Can GH therapy improve final height after HCT?

Growth gains continued beyond the first year of treatment, while irradiation and other transplant-related factors influenced response.

• by Andrea Surnit

• August 13, 2026

• 6 min